Similar articles

• Bioavailability of digoxin in man after oral administration of preparations with different dissolution rate.

  Nyberg L. Nyberg L. Acta Pharmacol Toxicol (Copenh). 1977;40 Suppl 3:1-48. Acta Pharmacol Toxicol (Copenh). 1977. PMID: 301340 No abstract available.
• [Clinical pharmacology of digoxin (review of the literature)].

  Gorchakova NA, Golota LG. Gorchakova NA, et al. Vrach Delo. 1978 Feb;(2):76-80. Vrach Delo. 1978. PMID: 347715 Review. Russian. No abstract available.
• [Clinical study of the biological availability of lanatoside C and digoxin in long-term tests].

  Bodem G, Ochs H, Hahn E, Dengler HJ. Bodem G, et al. Schweiz Med Wochenschr. 1977 May 14;107(19):658-66. Schweiz Med Wochenschr. 1977. PMID: 867012 German.
• [Comparative studies on the bioequivalency of digoxin (Lanoxin) and of beta-methyldigoxin (Lanitop) in patients with cardiac insufficiency].

  Otten H, Gerloff J, Bodem G. Otten H, et al. Verh Dtsch Ges Kreislaufforsch. 1977;43:423-4. Verh Dtsch Ges Kreislaufforsch. 1977. PMID: 613676 German. No abstract available.
• [Various aspects of digoxin treatment].

  Preibisz J, Grzesiuk W. Preibisz J, et al. Pol Arch Med Wewn. 1980 Apr;63(4):411-6. Pol Arch Med Wewn. 1980. PMID: 6997836 Review. Polish. No abstract available.